1-20 of 82
Francine M. Foss
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Proteomic Profiles of Cytokine Release Syndromes Following Lisocabtagene Maraleucel and Idecabtagene Vicleucel

Abu-Sayeef Mirza, Alexander Pine, Yusuf Rasheed, Ramzi Hamouche, Etienne Leveille, George Goshua, Sean Gu, Yuxin Liu, Jennifer VanOudenhove, Noffar Bar, Natalia Neparidze, Francine M. Foss, Lohith Gowda, Iris Isufi, Stephanie Halene, Alfred I Lee, Stuart Seropian
Journal: Blood
Blood (2022) 140 (Supplement 1): 10410–10412.
https://doi.org/10.1182/blood-2022-168374
Published: 2022
Journal Articles

Impact of Age on Outcomes after CD19 Directed CAR T Cell Therapy for Large B Cell Lymphomas: Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR)

Abu-Sayeef Mirza, Chitra Hosing, Francine M. Foss, Soyoung Kim, Amy Moskop, Temitope Oloyede, Sairah Ahmed, Peiman Hematti, Cameron J. Turtle, Marcelo C. Pasquini, Lohith Gowda
Journal: Blood
Blood (2022) 140 (Supplement 1): 4633–4635.
https://doi.org/10.1182/blood-2022-163750
Published: 2022
Journal Articles

Incorporation of Machine Learning Tools to Predict Global Outcomes for Patients with Relapsed and Refractory Peripheral T and NK/T-Cell Lymphomas in the Contemporary Era

Leora S Boussi, Min Jung Koh, Xinyi Han, Luke Peng, Min Ji Koh, Ijeoma Eche, Josie Germain Ford, Shambhavi Singh, Eliana Miranda, Carlos S. Chiattone, Carrie Van Der Weyden, Henry Miles Prince, Francine M. Foss, Sang Eun Yoon, Won-Seog Kim, Girisha Panchoo, Estelle Verburgh, Jackielyn Cuenca Alturas, Mubarak Al-mansour, Martina Manni, Massimo Federico, Maria Elena Cabrera, Beatrice Casadei, Pier Luigi Zinzani, Noriaki Yoshida, Takeshi Okatani, Mwanasha H. Merrill, Eric D Jacobsen, Owen A. O'Connor, Enrica Marchi, Salvia Jain
Journal: Blood
Blood (2022) 140 (Supplement 1): 10976–10978.
https://doi.org/10.1182/blood-2022-162944
Published: 2022
Journal Articles

Efficacy and Safety of E7777 (improved purity Denileukin diftitox [ONTAK]) in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma: Results from Pivotal Study 302

Francine M. Foss, Youn H. Kim, H. Miles Miles Prince, Timothy M. Kuzel, Costas K. Yannakou, Chean Eng Ooi, Dongyuan Xing, Nicholas Sauter, Preeti Singh, Myron Czuczman, Madeleine Duvic
Journal: Blood
Blood (2022) 140 (Supplement 1): 1491–1492.
https://doi.org/10.1182/blood-2022-166916
Published: 2022
Journal Articles

Total Costs of Care during Chimeric Antigen Receptor T-Cell Therapy in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma: A Large Private Insurance Claim-Based Analysis

Mengyang Di, Jessica B Long, Iris Isufi, Francine M. Foss, Stuart Seropian, Cary P Gross, Scott F. Huntington
Journal: Blood
Blood (2022) 140 (Supplement 1): 10818–10819.
https://doi.org/10.1182/blood-2022-164915
Published: 2022
Journal Articles

Safety and Tolerability of E7777 (improved purity Denileukin diftitox [ONTAK]) in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma: Results from Pivotal Study 302

H. Miles Miles Prince, Larisa J Geskin, Oleg E Akilov, Timothy M. Kuzel, Christiane Querfeld, Chean Eng Ooi, Dongyuan Xing, Nicholas Sauter, Preeti Singh, Myron Czuczman, Francine M. Foss
Journal: Blood
Blood (2022) 140 (Supplement 1): 6577–6578.
https://doi.org/10.1182/blood-2022-167564
Published: 2022
Journal Articles

Age, Albumin, and LDH Predict Outcome of Patients with Limited Stage Peripheral T Cell Lymphoma: A Prognostic Model Developed on 244 Cases Enrolled in the T Cell Project 1 By the International T Cell Project Network

Greg Hapgood, Monica Civallero, Yana Stepanishyna, Julie M. Vose, Maria Elena Cabrera, Ranjana H. Advani, Stefano A Pileri, Martina Manni, Steven M. Horwitz, Francine M. Foss, Felicitas Hitz, John Radford, Ivan Dlouhy, Carlos S. Chiattone, Won-Seog Kim, Tetiana Skrypets, Arnon Nagler, Judith Trotman, Stefano Luminari, Massimo Federico
Journal: Blood
Blood (2022) 140 (Supplement 1): 1476–1478.
https://doi.org/10.1182/blood-2022-158883
Published: 2022
Journal Articles

Differences in Progression and Survival Among Black Patients with Mycosis Fungoides and Sézary Syndrome: A Multicenter Retrospective Analysis at Large Urban Medical Centers

Pamela B. Allen, Subir Goyal, Swaminathan P. Iyer, Sai Talluru, Auris Huen, Irl Brian Greenwell, Jane Scribner, Shel Speegle, Tim Niyogusaba, Sunil Rangarajan, Amitkumar Mehta, Colin B. O'Leary, Anne W. Beaven, Jeffrey M. Switchenko, Amy Ayers, Safiyyah Bhatti, Shalini Krishnasamy, Pierluigi Porcu, Tarsheen Sethi, Francine M. Foss, Mary Jo Lechowicz, Sima Rozati
Journal: Blood
Blood (2022) 140 (Supplement 1): 9431–9433.
https://doi.org/10.1182/blood-2022-170921
Published: 2022
Journal Articles

A Phase I California Cancer Consortium Study of Blinatumomab/Lenalidomide in Relapsed/Refractory Non-Hodgkin Lymphoma: Updated Results and Immune Correlative Analyses

Tamer Othman, Christopher Ruel, Paul Frankel, Alexander A. Merleev, Guillaume Luxardi, Emanual Maverakis, Mehrdad Abedi, Raghuveer Ranganathan, Jasmine Zain, Lihua E Budde, Matthew Mei, Aaron S Rosenberg, Rasmus T Hoeg, Caitlin Costello, Francine M. Foss, Basem M. William, H. Kent Holland, Miguel Villalona-Calero, Elad Sharon, Joseph M Tuscano
Journal: Blood
Blood (2022) 140 (Supplement 1): 9446–9447.
https://doi.org/10.1182/blood-2022-167173
Published: 2022
Journal Articles

A Global Phase 2 Study of Valemetostat Tosylate (Valemetostat) in Patients with Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL), Including R/R Adult T-Cell Leukemia/Lymphoma (ATL) - Valentine-PTCL01

Francine M. Foss, Pierluigi Porcu, Steven M. Horwitz, Koji Izutsu, Kenji Ishitsuka, Kazunobu Kato, Jin Jin, Yining Du, Ai Inoue
Journal: Blood
Blood (2021) 138 (Supplement 1): 2533.
https://doi.org/10.1182/blood-2021-144676
Published: 2021
Journal Articles

Novel Single Agents Are Equivalent to Conventional Chemotherapy Inpatients with Relapsed and Refractory Mature T-Cell Lymphomas: A Meta-Analysis

Nazila Shafagati, Robert N. Stuver, Leora Boussi, Min Jung Koh, Allison Park, Paul Bain, Francine M. Foss, Changyu Shen, Salvia Jain
Journal: Blood
Blood (2021) 138 (Supplement 1): 1431.
https://doi.org/10.1182/blood-2021-150315
Published: 2021
Journal Articles

Response to Extracorporeal Photopheresis in Patients with Cutaneous T-Cell Lymphoma: A Retrospective Medical Chart Review

Michael Girardi, Amy G Johnson, Kacie Carlson, Xingyue Huang, Shelby Corman, Patrick Edmundson, Hrishikesh P Kale, Nifasha Rusibamayila, Francine M. Foss
Journal: Blood
Blood (2021) 138 (Supplement 1): 1405.
https://doi.org/10.1182/blood-2021-151116
Published: 2021
Journal Articles

EPOCH Is a Safe and Effective Treatment Option for Aggressive T-Cell Lymphomas

Tarsheen Sethi, Rachael Gerstein, Molly Schiffer, Kejal Amin, Sonal Agarwal, Francine M. Foss
Journal: Blood
Blood (2021) 138 (Supplement 1): 4547.
https://doi.org/10.1182/blood-2021-151238
Published: 2021
Journal Articles

Comparative Analysis of Mature T-Cell and NK/T-Cell Lymphomas in Patients with and without HIV: Results from the NA-Accord and Complete Cohorts

Min Jung Koh, Mwanasha H. Merrill, Min Ji Koh, Robert N. Stuver, Carolyn D. Alonso, Francine M. Foss, Angel M. Mayor, M. John Gill, Marta Epeldegui, Edward Cachay, Jennifer E. Thorne, Michael J. Silverberg, Michael A. Horberg, Keri N. Atlhoff, Ank E. Nijhawan, Kathleen A. McGinnis, Charles S. Rabkin, Sonia Napravnik, Changyu Shen, Salvia Jain
Journal: Blood
Blood (2021) 138 (Supplement 1): 1380.
https://doi.org/10.1182/blood-2021-147837
Published: 2021
Journal Articles

Final Results from a Phase 2 Study of Tipifarnib in Subjects with Relapsed or Refractory Peripheral T-Cell Lymphoma

Thomas E. Witzig, Lubomir Sokol, Won Seog Kim, Fátima de la Cruz Vicente, Dolores Caballero, Ranjana Advani, Raquel de Oña, Ana Marin Niebla, María José Terol, Domingo Domenech Eva, Nawal Bendris, Julie Mackey Ahsan, Mollie Leoni, Francine M. Foss
Journal: Blood
Blood (2021) 138 (Supplement 1): 621.
https://doi.org/10.1182/blood-2021-147279
Published: 2021
Journal Articles

Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in T-Cell Prolymphocytic Leukemia (T-PLL): An Analysis from the CIBMTR

Hemant S. Murthy, MD, Kwang Woo Ahn, PhD, Noel Estrada-Merly, MS, Lohith Gowda, MD, Bhagirathbhai Dholaria, MBBS, Susan Bal, MDMBBS, Hassan B. Alkhateeb, MD, Deepa Jagadeesh, MDMPH, Betul Oran, MDMS, Ryotaro Nakamura, MD, Bart L. Scott, MD, Craig S. Sauter, MD, Francine M. Foss, MD, Mohamed A kharfan-Dabaja, MDMBA, Wael Saber, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-134793
Published: 2020
Journal Articles

A Once Daily, Oral, Triple Combination of BTK Inhibitor, mTOR Inhibitor and IMiD for Treatment of Relapsed/Refractory Richter's Transformation and De Novo Diffuse Large B-Cell Lymphoma

Anthony R. Mato, MD, Stephen J. Schuster, MD, Francine M. Foss, MD, Iris Isufi, MD, Shalin K. Kothari, MD, Wei Ding, MD PhD, Danielle M. Brander, MD, Andrea Sitlinger, MD, Allison C. Rosenthal, D.O., Jose F. Leis, MD PhD, Han W. Tun, MD, Kaitlin Kennard, RN, BSN, Allison R. Nelson, RN, Victoria Falco, BSN, Celina J. Komari, BS, Amber B. Koehler, PA-C, MS, Rachel Stowe, RN, Wei He, PhD, Albert Kearney, PhD, Min Gui, PhD, Tim McKinlay, Lindsey E Roeker, MD, Meghan C. Thompson, MD, Scott F. Huntington, MD MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-138896
Published: 2020
Journal Articles

Successful Treatment of Mature T-Cell Lymphoma with Allogeneic Stem Cell Transplantation: The Largest Multicenter Retrospective Analysis

Neha Mehta-Shah, MD, Ajitha Kommalapati, MD, Stephanie Teja, MD, Amanda F Cashen, MD, Parastoo B. Dahi, MD, Craig S. Sauter, MD, Alison J. Moskowitz, MD, Eric D Jacobsen, MD, Basem M. William, MDMRCP, Michael Ozga, MD, Stefan K. Barta, MDMRCP,MS, Alison W. Loren, MD, Steven Bair, MD, Pamela B. Allen, MD MSc, Shahana Sulaiman, Kevin Song, MD, Musa Alzahrani, MBBS, MHSc, Jia Ruan, MD PhD, Koen van Besien, MD PhD, Madhav Seshadri, MD, Matthew McKinney, Anne W. Beaven, MD, Bradley Haverkos, MD MPH, MS, Adam Starr, MD, Onder Alpdogan, MD, Pierluigi Porcu, MD, Francine M. Foss, MD, Yu Tao, MD, Steven M. Horwitz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–36.
https://doi.org/10.1182/blood-2020-138542
Published: 2020
Journal Articles

Weekly Dosing Schedule of Brentuximab Vedotin in Mycosis Fungoides/Sezary Syndrome and Aggressive T Cell Lymphomas

Megan Lee, BS, Molly Schiffer, PharmD, Iris Isufi, MD, Scott F. Huntington, MD MPH, Mina L. Xu, MD, Stuart Seropian, MD, Lohith Gowda, MD, Shalin K. Kothari, MD, Michael Girardi, MD PhD, Francine M. Foss, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-139790
Published: 2020
Journal Articles

A Phase I Study of Anti-ICOS Antibody MEDI-570 for Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL) and Angioimmunoblastic T-Cell Lymphoma (AITL) (NCI-9930)

Julio C. Chavez, MD, Francine M. Foss, MD, Basem M. William, MDMRCP, Jonathan E Brammer, MD, Sonali M. Smith, MD, Anca Prica, MD, Jasmine M. Zain, MD, Joseph M Tuscano, MD, Martha Glenn, MD, Neha Mehta-Shah, MD, Ben X Wang, Stephanie Zantinge, Lisa Wang, Ling Zhang, MD, Anmarie Boutrin, Weiguang Zhao, Lily Cheng, Nathan Standifer, Gianluca Carlesso, Jeffrey Moscow, Lillian Siu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
https://doi.org/10.1182/blood-2020-136465
Published: 2020